Stock Markets

ClearOne Receives NASDAQ Deficiency Notification Letter

SALT LAKE CITY, May 18, 2018 -- ClearOne (NASDAQ: CLRO), a global provider of audio and visual communications solutions, today announced, in accordance with NASDAQ Rules, that it received a notification letter from staff of the NASDAQ Listing Qualifications Department, dated May 16, 2018, stating that ClearOne is not in compliance with NASDAQ Listing Rule 5250(c)(1), which requires timely filing of periodic reports with the Securities and Exchange Commission (SEC). The letter was issued in accordance...

Published on .

American River Bankshares Announces its 2018 Annual Meeting Results

SACRAMENTO, Calif., May 18, 2018 -- The Board of Directors of American River Bankshares (NASDAQ-GS:AMRB), announced the election of all nine Director nominees at its Annual Meeting held Thursday, May 17th in Rancho Cordova, California. Shareholders elected Nicolas C. Anderson, Kimberly A. Box, Charles D. Fite, Jeffery Owensby, William A. Robotham, David E. Ritchie, Jr. Stephen H. Waks, Philip A. Wright, Michael A. Ziegler as Directors, each of whose current term expired at the 2018 Annual Meeting...

Published on .

Risk Analytics Market - Opportunity Mapping in Terms of Technological Breakthroughs

Albany, NY -- 05/18/2018 -- Risk analytics assist organizations in knowing the certain risk existing in their businesses. Risk analytics tools help companies to derive risk-aware decisions and thus improving their business performance. Alongside this, risk analytics tools improve return on capital and reduces cost involved in regulatory compliance. With enterprises thriving to reduce the catastrophic losses, adoption of risk analytics tools have seen an uprising trend in recent years. Moreover,...

Published on .

Solid Biosciences Announces New Preclinical Data at the American Society of Gene and Cell Therapy Annual Meeting

- Data Reinforce Potential of SGT-001 as an Important Treatment Candidate for DMD -        - Company Continues to Advance Gene Therapy Portfolio -CAMBRIDGE, Mass., May 18, 2018 -- Solid Biosciences Inc. (NASDAQ:SLDB) today announced the presentation of new preclinical data from its gene therapy development programs for Duchenne muscular dystrophy (DMD). New data for SGT-001, the Company’s lead microdystrophin gene transfer candidate, further demonstrate its...

Published on .

Voyager Therapeutics Announces Additional Data at the American Society of Gene and Cell Therapy 2018 Annual Meeting

Voyager’s gene therapy vector for Friedreich’s ataxia prevents central and peripheral disease progression in preclinical model out to one year after a single administrationDurable safety data generated with Voyager’s novel AAV gene therapy capsids along with widespread gene transfer to the brain and spinal cord of non-human primates after a single intravenous administrationCAMBRIDGE, Mass., May 18, 2018 -- Voyager Therapeutics, Inc. (NASDAQ:VYGR), a clinical-stage gene therapy company focused...

Published on .

UTC Climate, Controls & Security Signs Definitive Agreement to Sell Taylor Company

PALM BEACH GARDENS, Fla., May 18, 2018 -- UTC Climate, Controls & Security, a unit of United Technologies Corp. (NYSE: UTX), has signed a definitive agreement to sell Taylor Company to The Middleby Corporation (NASDAQ: MIDD), a publicly traded company in the foodservice industry. The sale is expected to close early in the third quarter, subject to customary closing conditions, including regulatory approvals. UTC Climate, Controls & Security is a leading provider of integrated building solutions,...

Published on .

CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

EDEN PRAIRIE, Minn., May 18, 2018 -- CHF Solutions, Inc. (NASDAQ:CHFS), today announced that on May 16, 2018, the independent directors approved six equity awards under CHF Solution’s New-Hire Equity Incentive Plan, as material inducements to six individuals entering into employment with the Company.  The equity awards were approved in accordance with NASDAQ Listing Rule 5635(c)(4), which also requires a public announcement of equity awards that are not made under a stockholder approved equity...

Published on .

CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

EDEN PRAIRIE, Minn., May 18, 2018 -- CHF Solutions, Inc. (NASDAQ:CHFS), today announced that on May 16, 2018, the independent directors approved six equity awards under CHF Solution’s New-Hire Equity Incentive Plan, as material inducements to six individuals entering into employment with the Company.  The equity awards were approved in accordance with NASDAQ Listing Rule 5635(c)(4), which also requires a public announcement of equity awards that are not made under a stockholder approved equity...

Published on .

BK Ultrasound, Powered by Analogic, Launches bkSpecto Ultrasound System for Urology at the 2018 American Urological Association Annual Meeting

PEABODY, Mass., May 18, 2018 -- Analogic Corporation (Nasdaq:ALOG), enabling the world’s medical imaging and aviation security technology, today announced that it will launch the bkSpecto™ ultrasound system at the 113th AUA (American Urological Association) Annual Meeting, May 18–21, in San Francisco.bkSpecto—taken from the Latin word Specto, meaning ‘I see’—is BK Ultrasound’s all-new ultrasound platform designed for clinical practices. bkSpecto combines BK’s advanced auto-optimization...

Published on .

BK Ultrasound, Powered by Analogic, Launches bkSpecto Ultrasound System for Urology at the 2018 American Urological Association Annual Meeting

PEABODY, Mass., May 18, 2018 -- Analogic Corporation (Nasdaq:ALOG), enabling the world’s medical imaging and aviation security technology, today announced that it will launch the bkSpecto™ ultrasound system at the 113th AUA (American Urological Association) Annual Meeting, May 18–21, in San Francisco.bkSpecto—taken from the Latin word Specto, meaning ‘I see’—is BK Ultrasound’s all-new ultrasound platform designed for clinical practices. bkSpecto combines BK’s advanced auto-optimization...

Published on .

Global Water Resources Reports Results of Director Election

PHOENIX, May 18, 2018 -- Global Water Resources Inc., ("the Company"), (NASDAQ:GWRS), (TSX:GWR), announced that the nominees listed in the Proxy Statement, dated April 6, 2018, for the 2018 Annual Meeting of Stockholders ("the Meeting") were selected as Directors of the Company. As of the March 27, 2018 record date for the determination of the shareholders entitled to notice of and to vote at the meeting, 19,631,266 shares of common stock were outstanding and eligible to vote. A total of 15,837,686...

Published on .

Global Water Resources Reports Results of Director Election

PHOENIX, May 18, 2018 -- Global Water Resources Inc., ("the Company"), (NASDAQ:GWRS), (TSX:GWR), announced that the nominees listed in the Proxy Statement, dated April 6, 2018, for the 2018 Annual Meeting of Stockholders ("the Meeting") were selected as Directors of the Company. As of the March 27, 2018 record date for the determination of the shareholders entitled to notice of and to vote at the meeting, 19,631,266 shares of common stock were outstanding and eligible to vote. A total of 15,837,686...

Published on .

Editas Medicine Reports Data Demonstrating Subretinal Injection of EDIT-101 Well-tolerated in Non-human Primates

CAMBRIDGE, Mass., May 18, 2018 -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced results from a pre-clinical study demonstrating that EDIT-101 was well-tolerated when administered to non-human primates (NHP) via subretinal injection. EDIT-101 is the Company’s experimental medicine for the treatment of Leber Congenital Amaurosis type 10 (LCA10).  The Company reported these data today in an oral presentation at the 21st Annual Meeting of the American Society...

Published on .

Editas Medicine Reports Data Demonstrating Subretinal Injection of EDIT-101 Well-tolerated in Non-human Primates

CAMBRIDGE, Mass., May 18, 2018 -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced results from a pre-clinical study demonstrating that EDIT-101 was well-tolerated when administered to non-human primates (NHP) via subretinal injection. EDIT-101 is the Company’s experimental medicine for the treatment of Leber Congenital Amaurosis type 10 (LCA10).  The Company reported these data today in an oral presentation at the 21st Annual Meeting of the American Society...

Published on .

FILO MINING ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS TO BE HELD JUNE 14, 2018

Fri, May 18, 2018 23:15 CET VANCOUVER, British Columbia, May 18, 2018 /CNW/ - Filo Mining Corp (TSX-V, Nasdaq First North: FIL) (“Filo Mining”, “Filo”, or the “Company”) is pleased to announce that its Annual General and Special Meeting of Shareholders will be held at Suite 2000, 885 West Georgia Street, Vancouver, British Columbia, V6C 3E8 on Thursday, June 14, 2018, at 10:00 a.m. (Pacific Daylight Time), for the following purposes: to receive the audited consolidated financial...

Published on .